These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 36758443)

  • 1. Mixture risk assessment and human biomonitoring: Lessons learnt from HBM4EU.
    Luijten M; Vlaanderen J; Kortenkamp A; Antignac JP; Barouki R; Bil W; van den Brand A; den Braver-Sewradj S; van Klaveren J; Mengelers M; Ottenbros I; Rantakokko P; Kolossa-Gehring M; Lebret E
    Int J Hyg Environ Health; 2023 Apr; 249():114135. PubMed ID: 36758443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of human biomonitoring data to support policy development, raise awareness and environmental public health protection among countries within the HBM4EU project.
    Ubong D; Stewart L; Sepai O; Knudsen LE; Berman T; Reynders H; Van Campenhout K; Katsonouri A; Van Nieuwenhuyse A; Ingelido AM; Castaño A; Pedraza-Díaz S; Eiríksdóttir ÁV; Thomsen C; Hartmann C; Gjorgjev D; De Felip E; Tolonen H; Santonen T; Klanova J; Norström K; Kononenko L; Silva MJ; Uhl M; Kolossa-Gehring M; Apel P; Jõemaa M; Jajcaj M; Estokova M; Luijten M; Lebret E; von Goetz N; Holcer NJ; Probst-Hensch N; Cavaleiro R; Barouki R; Tarroja E; Balčienė RM; Strumylaite L; Latvala S; Namorado S; Szigeti T; Ingi Halldorsson T; Olafsdottir K; Wasowicz W;
    Int J Hyg Environ Health; 2023 Jun; 251():114170. PubMed ID: 37207539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human biomonitoring initiative (HBM4EU) - Strategy to derive human biomonitoring guidance values (HBM-GVs) for health risk assessment.
    Apel P; Rousselle C; Lange R; Sissoko F; Kolossa-Gehring M; Ougier E
    Int J Hyg Environ Health; 2020 Sep; 230():113622. PubMed ID: 33045523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human biomonitoring in health risk assessment in Europe: Current practices and recommendations for the future.
    Louro H; Heinälä M; Bessems J; Buekers J; Vermeire T; Woutersen M; van Engelen J; Borges T; Rousselle C; Ougier E; Alvito P; Martins C; Assunção R; Silva MJ; Pronk A; Schaddelee-Scholten B; Del Carmen Gonzalez M; de Alba M; Castaño A; Viegas S; Humar-Juric T; Kononenko L; Lampen A; Vinggaard AM; Schoeters G; Kolossa-Gehring M; Santonen T
    Int J Hyg Environ Health; 2019 Jun; 222(5):727-737. PubMed ID: 31176761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How to use human biomonitoring in chemical risk assessment: Methodological aspects, recommendations, and lessons learned from HBM4EU.
    Santonen T; Mahiout S; Alvito P; Apel P; Bessems J; Bil W; Borges T; Bose-O'Reilly S; Buekers J; Cañas Portilla AI; Calvo AC; de Alba González M; Domínguez-Morueco N; López ME; Falnoga I; Gerofke A; Caballero MDCG; Horvat M; Huuskonen P; Kadikis N; Kolossa-Gehring M; Lange R; Louro H; Martins C; Meslin M; Niemann L; Díaz SP; Plichta V; Porras SP; Rousselle C; Scholten B; Silva MJ; Šlejkovec Z; Tratnik JS; Joksić AŠ; Tarazona JV; Uhl M; Van Nieuwenhuyse A; Viegas S; Vinggaard AM; Woutersen M; Schoeters G
    Int J Hyg Environ Health; 2023 Apr; 249():114139. PubMed ID: 36870229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of Policy Relevant Human Biomonitoring Indicators for Chemical Exposure in the European Population.
    Buekers J; David M; Koppen G; Bessems J; Scheringer M; Lebret E; Sarigiannis D; Kolossa-Gehring M; Berglund M; Schoeters G; Trier X
    Int J Environ Res Public Health; 2018 Sep; 15(10):. PubMed ID: 30248963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phthalates and substitute plasticizers: Main achievements from the European human biomonitoring initiative HBM4EU.
    Gerofke A; Lange R; Vogel N; Schmidt P; Weber T; David M; Frederiksen H; Baken K; Govarts E; Gilles L; Martin LR; Martinsone Ž; Santonen T; Schoeters G; Scheringer M; Domínguez-Romero E; López ME; Calvo AC; Koch HM; Apel P; Kolossa-Gehring M
    Int J Hyg Environ Health; 2024 Jun; 259():114378. PubMed ID: 38631089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HBM4EU results support the Chemicals' Strategy for Sustainability and the Zero-Pollution Action Plan.
    Lobo Vicente J; Ganzleben C; Gasol R; Marnane I; Gilles L; Buekers J; Bessems J; Colles A; Gerofke A; David M; Barouki R; Uhl M; Sepai O; Loots I; Crabbé A; Coertjens D; Kolossa-Gehring M; Schoeters G
    Int J Hyg Environ Health; 2023 Mar; 248():114111. PubMed ID: 36706581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Towards a systematic use of effect biomarkers in population and occupational biomonitoring.
    Zare Jeddi M; Hopf NB; Viegas S; Price AB; Paini A; van Thriel C; Benfenati E; Ndaw S; Bessems J; Behnisch PA; Leng G; Duca RC; Verhagen H; Cubadda F; Brennan L; Ali I; David A; Mustieles V; Fernandez MF; Louro H; Pasanen-Kase R
    Environ Int; 2021 Jan; 146():106257. PubMed ID: 33395925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Harmonization of Human Biomonitoring Studies in Europe: Characteristics of the HBM4EU-Aligned Studies Participants.
    Gilles L; Govarts E; Rodriguez Martin L; Andersson AM; Appenzeller BMR; Barbone F; Castaño A; Coertjens D; Den Hond E; Dzhedzheia V; Eržen I; López ME; Fábelová L; Fillol C; Franken C; Frederiksen H; Gabriel C; Haug LS; Horvat M; Halldórsson TI; Janasik B; Holcer NJ; Kakucs R; Karakitsios S; Katsonouri A; Klánová J; Kold-Jensen T; Kolossa-Gehring M; Konstantinou C; Koponen J; Lignell S; Lindroos AK; Makris KC; Mazej D; Morrens B; Murínová ĽP; Namorado S; Pedraza-Diaz S; Peisker J; Probst-Hensch N; Rambaud L; Rosolen V; Rucic E; Rüther M; Sarigiannis D; Tratnik JS; Standaert A; Stewart L; Szigeti T; Thomsen C; Tolonen H; Eiríksdóttir Á; Van Nieuwenhuyse A; Verheyen VJ; Vlaanderen J; Vogel N; Wasowicz W; Weber T; Zock JP; Sepai O; Schoeters G
    Int J Environ Res Public Health; 2022 Jun; 19(11):. PubMed ID: 35682369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HBM4EU feasibility studies: Lessons learned in combining health and human biomonitoring studies.
    Elonheimo HM; Uusitalo K; Moore S; Andersson AM; Baber R; Wirkner K; David M; Kolossa-Gehring M; Stewart L; Sepai O; Lermen D; Bartel-Steinbach M; Rantakokko P; Koponen J; Tolonen H
    Int J Hyg Environ Health; 2023 Mar; 248():114100. PubMed ID: 36508963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemical prioritisation strategy in the European Human Biomonitoring Initiative (HBM4EU) - Development and results.
    Ougier E; Ganzleben C; Lecoq P; Bessems J; David M; Schoeters G; Lange R; Meslin M; Uhl M; Kolossa-Gehring M; Rousselle C; Vicente JL
    Int J Hyg Environ Health; 2021 Jul; 236():113778. PubMed ID: 34089975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Human Biomonitoring for Europe (HBM4EU)-first insights into the results of the initiative].
    Weise P; Apel P; Kolossa-Gehring M
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2022 Sep; 65(9):936-939. PubMed ID: 35997778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coordination of chemical analyses under the European Human Biomonitoring Initiative (HBM4EU): Concepts, procedures and lessons learnt.
    Vorkamp K; Esteban López M; Gilles L; Göen T; Govarts E; Hajeb P; Katsonouri A; Knudsen LE; Kolossa-Gehring M; Lindh C; Nübler S; Pedraza-Díaz S; Santonen T; Castaño A
    Int J Hyg Environ Health; 2023 Jun; 251():114183. PubMed ID: 37148759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The European Human Biomonitoring Initiative (HBM4EU): Human biomonitoring guidance values for selected phthalates and a substitute plasticizer.
    Lange R; Apel P; Rousselle C; Charles S; Sissoko F; Kolossa-Gehring M; Ougier E
    Int J Hyg Environ Health; 2021 May; 234():113722. PubMed ID: 33711757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxicity Weighting for Human Biomonitoring Mixture Risk Assessment: A Proof of Concept.
    Loh MM; Schmidt P; Christopher de Vries Y; Vogel N; Kolossa-Gehring M; Vlaanderen J; Lebret E; Luijten M
    Toxics; 2023 Apr; 11(5):. PubMed ID: 37235224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human biomonitoring initiative (HBM4EU): Human biomonitoring guidance values (HBM-GVs) derived for bisphenol A.
    Ougier E; Zeman F; Antignac JP; Rousselle C; Lange R; Kolossa-Gehring M; Apel P
    Environ Int; 2021 Sep; 154():106563. PubMed ID: 33894553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The questionnaire design process in the European Human Biomonitoring Initiative (HBM4EU).
    González-Alzaga B; Hernández AF; Kim Pack L; Iavicoli I; Tolonen H; Santonen T; Vinceti M; Filippini T; Moshammer H; Probst-Hensch N; Kolossa-Gehring M; Lacasaña M
    Environ Int; 2022 Feb; 160():107071. PubMed ID: 34979351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemical Mixtures in the EU Population: Composition and Potential Risks.
    Socianu S; Bopp SK; Govarts E; Gilles L; Buekers J; Kolossa-Gehring M; Backhaus T; Franco A
    Int J Environ Res Public Health; 2022 May; 19(10):. PubMed ID: 35627658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substitutes mimic the exposure behaviour of REACH regulated phthalates - A review of the German HBM system on the example of plasticizers.
    Lemke N; Murawski A; Lange R; Weber T; Apel P; Dębiak M; Koch HM; Kolossa-Gehring M
    Int J Hyg Environ Health; 2021 Jul; 236():113780. PubMed ID: 34126298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.